Rein Therapeutics Inc. (RNTX)
NASDAQ: RNTX · Real-Time Price · USD
1.020
0.00 (0.00%)
At close: May 5, 2026, 4:00 PM EDT
1.010
-0.010 (-0.98%)
After-hours: May 5, 2026, 6:45 PM EDT
Rein Therapeutics Market Cap
Rein Therapeutics has a market cap or net worth of $28.6 million as of May 5, 2026. Its market cap has decreased by -23.53% in one year.
Market Cap
28.60M
Enterprise Value
25.38M
1-Year Change
-23.53%
Ranking
Category
Stock Price
$1.02
Market Cap Chart
Since June 29, 2017, Rein Therapeutics's market cap has decreased from $158.90M to $28.60M, a decrease of -82.00%. That is a compound annual growth rate of -17.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 4, 2026 | 28.60M | -6.23% |
| Dec 31, 2025 | 30.50M | -38.76% |
| Dec 31, 2024 | 49.80M | 260.87% |
| Dec 29, 2023 | 13.80M | 27.78% |
| Dec 30, 2022 | 10.80M | -78.82% |
| Dec 31, 2021 | 51.00M | 20.57% |
| Dec 31, 2020 | 42.30M | 166.04% |
| Dec 31, 2019 | 15.90M | 28.23% |
| Dec 31, 2018 | 12.40M | -92.01% |
| Dec 29, 2017 | 155.10M | -2.39% |
| Jun 29, 2017 | 158.90M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tempest Therapeutics | 30.12M |
| Senti Biosciences Holdings | 29.75M |
| BriaCell Therapeutics | 29.52M |
| Lisata Therapeutics | 29.45M |
| Kyntra Bio | 29.02M |
| Neuphoria Therapeutics | 28.57M |
| Dyadic International | 28.31M |
| Polyrizon | 27.63M |